Sclerostin and osteocalcin: candidate bone-produced hormones

JS Wang, CM Mazur, MN Wein - Frontiers in Endocrinology, 2021 - frontiersin.org
In addition to its structural role, the skeleton serves as an endocrine organ that controls
mineral metabolism and energy homeostasis. Three major cell types in bone-osteoblasts …

Organ aging signatures in the plasma proteome track health and disease

HSH Oh, J Rutledge, D Nachun, R Pálovics, O Abiose… - Nature, 2023 - nature.com
Animal studies show aging varies between individuals as well as between organs within an
individual,,–, but whether this is true in humans and its effect on age-related diseases is …

Role of sclerostin in cardiovascular disease

J Golledge, S Thanigaimani - Arteriosclerosis, Thrombosis, and …, 2022 - Am Heart Assoc
Sclerostin is most recognized for its role in controlling bone formation but is also expressed
in the heart, aorta, coronary, and peripheral arteries. This review summarizes research on …

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease

FC Alves, J Sun, AR Qureshi, L Dai, S Snaedal… - PloS one, 2018 - journals.plos.org
Background The correlation of low serum albumin with mortality in patients with chronic
kidney disease (CKD) is partly linked to its association with systemic inflammation. However …

Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease

AMG Jaminon, L Dai, AR Qureshi, P Evenepoel… - Scientific reports, 2020 - nature.com
Matrix Gla protein (MGP) is a potent inhibitor of vascular calcification (VC) and requires
carboxylation by vitamin K to exert calcification inhibition. Chronic kidney disease (CKD) …

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients

L Dai, H Mukai, B Lindholm, O Heimbürger, P Barany… - PloS one, 2017 - journals.plos.org
Background The value of subjective global assessment (SGA) as nutritional assessor of
protein-energy wasting (PEWSGA) in chronic kidney disease (CKD) patients depends on its …

[HTML][HTML] Identifying early pathogenic events during vascular calcification in uremic rats

L Hortells, C Sosa, N Guillén, S Lucea, Á Millán… - Kidney international, 2017 - Elsevier
Vascular calcification in chronic kidney disease is a very complex process traditionally
explained in multifactorial terms. Here we sought to clarify relevance of the diverse agents …

Bone mineral density and mortality in end-stage renal disease patients

K Iseri, L Dai, Z Chen, AR Qureshi… - Clinical kidney …, 2020 - academic.oup.com
Osteoporosis characterized by low bone mineral density (BMD) as assessed by dual-energy
X-ray absorptiometry (DXA) is common among end-stage renal disease (ESRD) patients …

Reduced skeletal muscle expression of mitochondrial-derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease

C Liu, EK Gidlund, A Witasp… - American Journal …, 2019 - journals.physiology.org
Advanced chronic kidney disease (CKD) is characterized by a premature aging phenotype
of multifactorial origin. Mitochondrial dysfunction is prevalent in CKD and has been …

Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease

S Salam, O Gallagher, F Gossiel, M Paggiosi, R Eastell… - Bone, 2021 - Elsevier
Background Vascular calcification (VC) and renal osteodystrophy are important
complications of advanced chronic kidney disease (CKD). High resolution peripheral …